For example, PS‐80 coated PBCA nanoparticles loaded with nerve growth factor were administered in a drug‐induced Parkinson's disease rat model,[240] and a reduction in Parkinson's symptoms such as orientation‐research reaction, rigidity and tremor, and locomotor activity were observed. The gene discussed is NGF; the disease is Parkinson disease.